calendar
701 catalysts · 3,369 8k filing · 1,458 grant · 1,000 device adverse event · 701 approval · 582 earnings · 540 device 510k
701 catalysts · 3,369 8k filing · 1,458 grant · 1,000 device adverse event · 701 approval · 582 earnings · 540 device 510k
no tagged catalysts yet
Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL
Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION
Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL
Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL
Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: QILU. Form: INJECTABLE. Route: INJECTION
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL
Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL
Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: RIDGEBACK BIOTHERAPEUTICS. Form: POWDER. Route: IV (INFUSION)
Sponsor: IPCA LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION
Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION
Sponsor: MSN. Form: SOLUTION. Route: ORAL
Sponsor: KYOWA KIRIN. Form: INJECTABLE. Route: INJECTION
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL
Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS